24小时DIEP挑战:ERAS如何重新定义显微外科乳房重建的康复
本研究基于前瞻性机构数据库回顾性分析2023年1月至2025年7月连续127例(143皮瓣)DIEP乳房重建患者,比较ERAS实施前后结局。ERAS组单侧住院日从3.69±1.18天降至1.78±0.80天(p<0.001),32.2%患者24小时内出院,手术时间单侧减少25.3%、双侧减少24.3%(均p<0.001),并发症率无差异。
要点
- ERAS路径使单侧DIEP重建住院日从3.69天降至1.78天,32.2%患者24小时内出院。
- ERAS独立关联住院日缩短50.9%,BMI是延长住院的唯一预测因素。
- 单侧和双侧手术时间分别减少25.3%和24.3%,并发症率无差异。
核心结论
- 结构化ERAS路径可实现DIEP乳房重建后安全可重复的24小时出院,不增加并发症。
研究设计与样本
- 回顾性分析前瞻性机构数据库,纳入2023年1月至2025年7月连续127例(143皮瓣)单侧/双侧DIEP乳房重建患者,比较ERAS实施前(37例)与实施后(90例)结局。
主要发现
- 单侧重建住院日从3.69±1.18天降至1.78±0.80天(p<0.001),双侧从6.00±2.92天降至3.18±0.60天(p=0.096)。
- 单侧手术时间减少25.3%,双侧减少24.3%(均p<0.001)。
- ERAS独立关联住院日缩短50.9%,BMI是延长住院的唯一预测因素。
- 并发症率组间无差异,患者报告满意度高,2天内出院者更高。
临床怎么用
- 可参考该DIEP特异性ERAS路径实施标准化围手术期管理和多学科协调,以优化康复、手术效率和患者满意度。
局限性
- 回顾性分析,双侧重建住院日差异未达统计学显著(p=0.096)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Enhanced recovery after surgery (ERAS) protocols have reshaped perioperative management in microsurgical breast reconstruction. However, evidence supporting safe and reproducible ultra-early discharge following deep inferior epigastric perforator (DIEP) flap reconstruction remains limited. We evaluated a DIEP-specific ERAS pathway designed to facilitate 24-hour discharge. METHODS: A retrospective analysis of a prospective institutional database included consecutive patients undergoing unilateral/bilateral DIEP flap breast reconstruction between January 2023 and July 2025. Outcomes before (pre-ERAS) and after ERAS implementation were compared. The primary endpoint was length of stay (LOS); secondary endpoints included operative time, postoperative complications, and patient-reported satisfaction. Multivariable robust regression assessed the independent effect of ERAS on LOS and operative time. RESULTS: A total of 127 patients (143 flaps) were included (37 pre-ERAS and 90 ERAS). In unilateral reconstructions, LOS decreased from 3.69 ± 1.18 to 1.78 ± 0.80 days (p < 0.001), and in bilateral reconstructions from 6.00 ± 2.92 to 3.18 ± 0.60 days (p = 0.096). Twenty-nine ERAS patients (32.2%) were discharged within 24 h. Operative time was reduced in unilateral (-25.3%) and bilateral (-24.3%) reconstructions (all p < 0.001). ERAS was independently associated with a 50.9% reduction in LOS; body mass index was the only predictor of prolonged hospitalization. Complications rates did not differ between the groups. Patient-reported satisfaction was high and greater among patients discharged within 2 days. CONCLUSIONS: A structured ERAS pathway enables safe and reproducible 24-hour discharge following DIEP flap breast reconstruction without increasing morbidity. Standardized perioperative care and multidisciplinary coordination optimizes recovery, operative efficiency, and patient satisfaction.
引用
- Longo B, Giacalone M, D'Orsi G, et al. The 24-hour DIEP challenge: How ERAS redefines recovery in microsurgical breast reconstruction. J Plast Reconstr Aesthet Surg. 2026. PMID: 42091419. doi:10.1016/j.bjps.2026.04.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。